Medical Device News Magazine

Scott Day New Telos Partners VP and General Manager

Day to Accelerate Growth Strategy

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Telos Partners LLC, a subsidiary of OrthoPediatrics Corporation (NASDAQ: KIDS), specializing in the delivery of regulatory, reimbursement, and clinician adoption and other consulting services to the orthopedic, spine, and wound care industries, is pleased to welcome Scott Day to the position of Senior VP and General Manager.

Scott Day assumes this role following the completion of Jason Inzana’s time leading the Telos organization.

Since being acquired by OrthoPediatrics, Telos has more than doubled the size of its team, streamlined its sales channel, and expanded its client base. The firm is poised to compete in a market where this client base faces unprecedented challenges associated with market entrance, sustainment, and growth barriers around the world.

Scott is a medical technology veteran, uniquely equipped to lead the Telos team forward on this foundation. As Senior Vice President of the Orthofix US orthopedic business unit, his leadership resulted in 31% growth during his 4+ year tenure. In Scott’s most recent position, Executive VP and Chief Operating Officer at Gramercy Extremity Orthopedics, he led the implementation and adoption of the company’s proprietary sterile-packaged, RFID-enabled solutions in renowned surgery centers and Integrated Delivery Networks (IDNs).

“As planned, Jason’s leadership has set Telos on a strong foundation for predictable revenue contribution to OrthoPediatrics,” commented Joel Batts, Sr. Vice President of Science and Technology at OrthoPediatrics. “Scott now takes the baton and leads the team into an aggressive growth mode that never compromises on the Telos commitment to deliver high-quality outcomes to meet the clients’ ultimate objective. The consistent business growth he has achieved through inspiring medical technology teams to perform spans start-ups to multi-national companies over nearly 20 years. It is a great privilege to welcome Scott to Telos.”

“Telos has some of the brightest, most capable minds in the industry and I could not be more excited to lead the firm at this stage in its lifecycle,” said Mr. Day. “Knowing the challenges on the immediate horizon, such as how companies innovate within an increasingly arduous regulatory environment, the Telos team stands ready to address the unique needs of existing and future clients.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”